Life sciences stories
The new framework is intended to help firms prove AI tools are reliable and compliant as regulators demand ongoing evidence, not one-off audits.
European firms needing secure, low-carbon compute gain a bigger home as the deal expands cloud, AI and dedicated HPC services under one roof.
Rising demand for genomic medicine in Australia and New Zealand is prompting the company to step up local partnerships and market expansion.
Businesses could see faster, cheaper AI coding and office workflows as OpenAI rolls out GPT-5.6 with stronger safeguards.
Android users will get new security and multitasking tools first, as Google rolls out Gemini 3.5 Live Translate and other updates.
The purchase bolsters Ecolab's push into AI data centres as demand for liquid cooling surges, with CoolIT sales more than doubling this year.
Researchers can now analyse data, search literature and draft papers in one place, with outputs kept reproducible on their own infrastructure.
Pharmaceutical researchers could speed up discovery workflows as Anthropic's new Claude Science beta gains access to NVIDIA's BioNeMo tools.
The move gives Altimetrik a role in shaping enterprise AI standards as firms struggle to embed new systems into legacy operations.
AI startups drove 57% of UK equity funding by value in Q2, as eight large rounds accounted for almost 80% of disclosed investment.
Most fintech startups could miss out on planned tax relief unless Treasury rewrites rules to reflect the sector's long, costly path to scale.
Owners are bringing security, networking and AV planning forward as repeat work lifts 27%, with CSP on track for 125 projects this year.
Many firms still lack grants and training as ministers' industrial push is judged on what reaches factory floors, Fluke research shows.
Healthcare providers face added pressure to secure AI systems and patient data as Rubrik joins a coalition of nearly 3,000 members.
Research papers at ICML 2026 increasingly leaned on Nvidia's chips and open models, underlining its reach across robotics, biomedicine and AI.
Smaller UK firms faced tighter funding in 2025 as AI deals drew 44% of equity investment, the British Business Bank said.
Recruitment delays at Canopy's sites could ease as a dedicated platform is set to cut missed follow-ups and lift enrolment rates.
Smaller UK businesses saw funding weaken as AI deals soaked up a record share of equity investment, despite overall market value slipping 4%.
The move gives the campus its first commercial occupier for The Sequence and adds 21,000 sq ft of labs for health start-ups.
The expansion will deepen Berkeley's ties with Japanese universities and government bodies as it scales bootcamps and founder exchange programmes.